Unknown

Dataset Information

0

Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.


ABSTRACT: SETTING: The ototoxic effects of aminoglycosides (AGs) lead to permanent hearing loss, which is one of the devastating consequences of multidrug-resistant tuberculosis (MDR-TB) treatment. As AG ototoxicity is dose-dependent, the impact of a surrogate measure of AG exposure on AG-induced hearing loss warrants close attention for settings with limited therapeutic drug monitoring.OBJECTIVE: To explore the prognostic impact of cumulative AG dose on AG ototoxicity in patients following initiation of AG-containing treatment for MDR-TB.DESIGN: This prospective cohort study was nested within an ongoing cluster-randomized trial of nurse case management intervention across 10 MDR-TB hospitals in South Africa.RESULTS: The adjusted hazard of AG regimen modification due to ototoxicity in the high-dose group (?75 mg/kg/week) was 1.33 times higher than in the low-dose group (<75 mg/kg/week, 95%CI 1.09-1.64). The adjusted hazard of developing audiometric hearing loss was 1.34 times higher than in the low-dose group (95%CI 1.01-1.77). Pre-existing hearing loss (adjusted hazard ratio [aHR] 1.71, 95%CI 1.29-2.26) and age (aHR 1.16 per 10 years of age, 95%CI 1.01-1.33) were also associated with an increased risk of hearing loss.CONCLUSION: MDR-TB patients with high AG dose, advanced age and pre-existing hearing loss have a significantly higher risk of AG-induced hearing loss. Those at high risk may be candidates for more frequent monitoring or AG-sparing regimens.

SUBMITTER: Hong H 

PROVIDER: S-EPMC7594545 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.

Hong H H   Dowdy D W DW   Dooley K E KE   Francis H W HW   Budhathoki C C   Han H-R HR   Farley J E JE  

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20200101 1


<b>SETTING:</b> The ototoxic effects of aminoglycosides (AGs) lead to permanent hearing loss, which is one of the devastating consequences of multidrug-resistant tuberculosis (MDR-TB) treatment. As AG ototoxicity is dose-dependent, the impact of a surrogate measure of AG exposure on AG-induced hearing loss warrants close attention for settings with limited therapeutic drug monitoring.<b>OBJECTIVE:</b> To explore the prognostic impact of cumulative AG dose on AG ototoxicity in patients following  ...[more]

Similar Datasets

| S-EPMC7456344 | biostudies-literature
| S-EPMC5328543 | biostudies-other
| S-EPMC5651232 | biostudies-literature
| S-EPMC7201259 | biostudies-literature
| S-EPMC6002855 | biostudies-literature
| S-EPMC2920322 | biostudies-other
| S-EPMC7322692 | biostudies-literature
| S-EPMC10146925 | biostudies-literature
| S-EPMC7927872 | biostudies-literature
| S-EPMC6030934 | biostudies-literature